Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.

In the per-protocol population, stroke or systemic embolism occurred in 188 patients who received rivaroxaban and 241 patients who received warfarin (1.7 vs 2.2%; hazard ratio [HR]: 0.79; ...

Our study is a step toward developing evidence-based clinical guidance to suggest apixaban as a safer choice than warfarin or ...

Adapted with permission from [9,21]. Events Rivaroxaban (number per 100 patient years) Warfarin (number per 100 patient years) Rivaroxaban versus warfarin hazard ratio (95% CI) Primary safety ...